Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
E Saâda-Bouzid, C Defaucheux, A Karabajakian, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2014
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia
C Even, P Pautier, P Duvillard, et al.
ESMO Open
|
August 25, 2023
Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022]
C van Herpen, V Vander Poorten, A Skalova, et al.
ESMO Open
|
December 25, 2022
Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up
C van Herpen, V Vander Poorten, A Skalova, et al.
Hepatology Communications
|
July 7, 2020
Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in Mice
Dieter Schmoll, Nicole Ziegler, Benoit Viollet, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
May 9, 2026
Sinonasal mucosal melanoma: REFCOR guidelines for diagnosis, treatment and follow-up
A Moya-Plana, M Khalaf, O Casiraghi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2021
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance
Y Loriot, A Marabelle, J P Guégan, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
May 9, 2026
REFCOR guidelines for sinonasal adenocarcinoma
L de Gabory, C Monnot, A-C Baglin, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
February 20, 2026
REFCOR guidelines for sinus and nasal cavity cancer
C-H Hassan, A-C Baglin, B Baujat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2021
Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?
A Laparra, M Kfoury, S Champiat, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
E Saâda-Bouzid, C Defaucheux, A Karabajakian, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2014
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia
C Even, P Pautier, P Duvillard, et al.
ESMO Open
|
August 25, 2023
Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022]
C van Herpen, V Vander Poorten, A Skalova, et al.
ESMO Open
|
December 25, 2022
Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up
C van Herpen, V Vander Poorten, A Skalova, et al.
Hepatology Communications
|
July 7, 2020
Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in Mice
Dieter Schmoll, Nicole Ziegler, Benoit Viollet, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
May 9, 2026
Sinonasal mucosal melanoma: REFCOR guidelines for diagnosis, treatment and follow-up
A Moya-Plana, M Khalaf, O Casiraghi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2021
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance
Y Loriot, A Marabelle, J P Guégan, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
May 9, 2026
REFCOR guidelines for sinonasal adenocarcinoma
L de Gabory, C Monnot, A-C Baglin, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
February 20, 2026
REFCOR guidelines for sinus and nasal cavity cancer
C-H Hassan, A-C Baglin, B Baujat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 18, 2021
Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?
A Laparra, M Kfoury, S Champiat, et al.
Page
of 18